Spectacular Effect of Massive Facial Angiofibromas Removal With a Carbon Dioxide Laser as a Manifestation of a Tuberous Sclerosis Complex TSC angiofibromas removal with CO2 laser
Journal of Lasers in Medical Sciences,
Vol. 12 (2021),
13 Bahman 2021
,
Page e24
Abstract
Introduction: Tuberous sclerosis complex (TSC) is a rare, genetic disease that leads to neurological, cardiological, nephrological, ophthalmic, pulmonary, and skin disorders.
Case Presentation: Here, we describe a case of a 64-year-old man with the presence of giant angiofibromas located on his chin and nasolabial folds which caused inconvenience and unaesthetic appearance. All angiofibromas were removed with the use of a CO2 laser. The patient was extremely satisfied with the obtained result. No side effects were observed after a 6-month follow-up.
Conclusion: Despite the fact that giant facial angiofibromas may be troublesome not only for patients but also for medical doctors, adequate CO2 laser usage with local anesthesia and control of massive bleeding is a promising treatment option for patients with TSC.
- Tuberous sclerosis; Tuberous sclerosis complex; Angiofibromas; Lasers; Carbon dioxide laser
How to Cite
References
Randle SC. Tuberous Sclerosis Complex: A Review. Pediatr Ann. 2017;46(4):e166-e71. doi: 10.3928/19382359-20170320-01
Annear NMP, Appleton RE, Bassi Z, Bhatt R, Bolton PF, Crawford P, et al. Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care. Front Neurol. 2019;10(1116). doi: 10.3389/
fneur.2019.01116
Bakić M, Ratković M, Gledović B, Vujović B, Radunović D, Babić V, et al. Cutaneous Manifestations of Tuberous
Sclerosis. Acta Dermatovenerol Croat. 2018; 26(1):73-4.
Wataya-Kaneda M, Uemura M, Fujita K, Hirata H, Osuga K, Kagitani-Shimono K, et al. Tuberous sclerosis complex: Recent advances in manifestations and therapy. Int J Urol. 2017;24(9):681-91. doi: 10.1111/iju.13390
Tsang SH, Sharma T. Tuberous Sclerosis. Adv Exp Med Biol. 2018; 1085:205-7. doi: 10.1007/978-3-319-95046-4_43
Curatolo P, Maria BL. Tuberous sclerosis. Handb Clin Neurol. 2013; 111:323-31. doi: 10.1016/B978-0-444-52891-
00038-5
MacKeigan JP, Krueger DA. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of
tuberous sclerosis complex. Neuro Oncol. 2015;17(12):1550-9. doi: 10.1093/neuonc/nov152
Papadavid E, Markey A, Bellaney G, Walker NPJ. Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br J Dermatol. 2002;147(2):337-42. doi: 10.1046/j.1365-2133.2002.04968.x
Ali FR, Mallipeddi R, Craythorne EE, Sheth N, AlNiaimi F. Our experience of carbon dioxide laser ablation of angiofibromas: Case series and literature review. J Cosmet Laser Ther. 2016 Nov;18(7):372-375. doi:
1080/14764172.2016.1197403
Weiss ET, Geronemus RG. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis. Lasers Surg Med. 2010;42(5):357-60. doi: 10.1002/lsm.20939.
Ma G, Wu P, Lin X, Chen H, Li W, Hu X, et al. Nd:YAG laser for „fractional“ treatment of angiofibromas. Int J Dermatol. 2014;53(5):638-42. doi: 10.1111/ijd.12384
- Abstract Viewed: 480 times
- PDF Downloaded: 407 times